Genomic therapy developer EdiGene, electric vehicle rental platform Go Sharing and API management platform developer RapidAPI have all raised about $60m.
Funding China-headquartered genomic drug developer EdiGene has closed a RMB400m ($61.6m) series B-plus round featuring Lilly Asia Ventures, a corporate venturing vehicle for pharmaceutical firm Eli Lilly. The round was led by Loyal Valley Capital and included BioTrack Capital, Sherpa Healthcare Partners and existing backers including IDG Capital, 3H Health Investment, Huagai Capital, Sequoia Capital…
This content is only accessible to subscribers. If you are a subscriber, please sign in. Otherwise, if you would like to try before you buy and haven't previously taken out a free trial, you can do so below. You can also see details on subscriptions by clicking the Subscription Options button.
Necessary cookies are absolutely essential for the website to function properly. This category only includes cookies that ensures basic functionalities and security features of the website. These cookies do not store any personal information.
Any cookies that may not be particularly necessary for the website to function and is used specifically to collect user personal data via analytics, ads, other embedded contents are termed as non-necessary cookies. It is mandatory to procure user consent prior to running these cookies on your website.